Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$194.44 - $217.61 $4,472 - $5,005
23 New
23 $4.51 Million
Q4 2022

Feb 14, 2023

BUY
$197.11 - $250.07 $591 - $750
3 Added 15.0%
23 $5,000
Q4 2021

Feb 14, 2022

BUY
$351.38 - $448.68 $1,054 - $1,346
3 Added 17.65%
20 $8,000
Q1 2021

May 14, 2021

BUY
$249.67 - $299.48 $4,244 - $5,091
17 New
17 $5,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Thomas J. Herzfeld Advisors, Inc. Portfolio

Follow Thomas J. Herzfeld Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thomas J. Herzfeld Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Thomas J. Herzfeld Advisors, Inc. with notifications on news.